Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001209191-21-021320

Chief Operating Officer sold 6,250 shares at $29.43 ($183,951)

  • Chief Operating Officer acquired 6,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

FORD KATHLEEN · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-15 Exercise or conversion : show line 1 in the form +6,250 $19.43 $121,438 6,250 D
2021-03-15 Sale : show line 2 in the form −6,250 $29.43 $183,951 0 D
Open-market sales · 6,250 sh · avg $29.43 · $183,951

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-03-15 Exercise or conversion : show line 3 in the form Option to purchase common stock −6,250 $19.43 2029-08-08 6,250 215,625 D
Loading xslF345X03/doc4.xml…